WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

DEVELOPMENT AND EVALUATION OF ANTI -HYPERTENSIVE DRUG LOADED SOLID LIPID NANO- PARTICLES

Manojkumar G. N., Ashok Kumar P.* Manjunath K. and Girisha G. R.

ABSTRACT

The intention of the present study was to design Doxazosin Mesylate solid lipid Nano-particles and to evaluate them. Doxazosin Mesylate solid lipid Nano-particles were prepared by hot homogenization technique using different lipids (Tristearin, GMS and Comprital), soy lecithin as stabilizers and tween 80 as surfactant, evaluated for particle size & PDI, zeta potential, entrapment efficiency and in vitro drug release. The particle size ranged from 35.88 to 571.3 nm. PDI of all formulations were good within the range of 0.136 to 0.600. The zeta potential of blank SLN of TS was ranged from – 15.2 mV to -18.4 mV whereas drug loaded SLN with TS showed zeta potential from -21.0 to -24.7mV. Whereas drug loaded SLN with GMS and CM ranged from -2.03 to 42.0. Entrapment efficiency was in the range of 78.68 to 95.23 %. The cumulative percentage release of doxazosin Mesylate from different Doxazosin Mesylate Nano-particles varied from 55.74 to 89.58% depending upon the drug lipid ratio and the type of lipid used. The average percentage of drug released from different SLNs after 24 hours showed in the following order: F7 (55.74%) < F6 (57.18%) < F4 (61.56%) < F8 (65.85%) < F5 (65.87%)

Keywords: Doxazosin Mesylate, solid lipid Nano-particles, FTIR, in vitro drug release.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More